Vaccinating boys along with girls against HPV not cost effective Clinical study 23 January 2013 Pages: 1 - 1
Patients may be safely vaccinated even after allergic reactions Media release 23 January 2013 Pages: 2 - 2
EASD studies shed light on costs of insulin initiation for T2DM News item 23 January 2013 Pages: 3 - 4
Micafungin appears to be cost saving versus caspofungin when used to treat candidaemia and invasive candidiasis Clinical study 23 January 2013 Pages: 8 - 8
Nearly one-fifth of eligible cancer patients in the US fail to receive Avastin [bevacizumab] due to its high cost Media release 23 January 2013 Pages: 8 - 8
Diabetes education economically rewarding in Austria, Germany Clinical study 23 January 2013 Pages: 9 - 9
Prescriptions for psychotropic drugs are mostly written by general practitioners (GPs) Media release 23 January 2013 Pages: 9 - 9
Systematic serum galactomannan screening may affect physicians' choices of antifungal treatments and bring about cost savings Clinical study 23 January 2013 Pages: 10 - 10
The United Nations Refugee Agency has boosted healthcare funding of its basic healthcare operations for displaced persons worldwide News item 23 January 2013 Pages: 11 - 11
The UN is seeking $1.48 billion and 300 million doses of the influenza A virus H1N1 ('swine flu') vaccine News item 23 January 2013 Pages: 11 - 11
The breast cancer drug market in China is expected to grow from $165 million in 2008 to $298 million in 2013 Media release 23 January 2013 Pages: 11 - 11
Lenalidomide [Revlimid] will be listed on the Australian Pharmaceutical Benefits Scheme from 1 November 2009 Media release 23 January 2013 Pages: 11 - 11